[ad_1] <br><a target="_blank" href="https://www.fiercebiotech.com/biotech/windtrees-phase-2-shock-med-rapidly-raises-blood-pressure-and-shares" rel="noopener">Windtree's cardiogenic shock medicine istaroxime met its phase 2 trial endpoint</a> <font color="#6f6f6f">FierceBiotech</font> <br>[ad_2] <br><a href="https://www.fiercebiotech.com/biotech/windtrees-phase-2-shock-med-rapidly-raises-blood-pressure-and-shares">Source link </a>